Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions

Journal of Neuroscience

Volumn 18, Issue 13, 1998, Pages 5078-5085

  McDonald, Michael P ^a   Willard, Lauren B ^b   Wenk, Gary L ^b   Crawley, Jacqueline N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Acetylcholine; Alzheimer's disease; Galanin; Lesion model; Memory; Muscarinic receptors; Neuropeptide

Indexed keywords

3 (3 N PENTYL 1,2,5 THIADIAZOL 4 YL) 1,2,5,6 TETRAHYDRO 1 METHYLPYRIDINE; CHOLINERGIC RECEPTOR; GALANIN; IMMUNOGLOBULIN G; IMMUNOTOXIN; MUSCARINIC M1 RECEPTOR AGONIST; NEUROPEPTIDE; SAPONIN; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC TRANSMISSION; COGNITION; COGNITIVE DEFECT; DIAGNOSTIC ACCURACY; MEMORY; MENTAL PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; TASK PERFORMANCE;

EID: 0032124854     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-13-05078.1998     Document Type: Article

References (60)

1. Bartfai T, Fisone G, Langel Ü (1992) Galanin and galanin antagonists: molecular and biochemical perspectives. Trends Pharmacol Sci 13:312-317.
2. Bartfai T, Langel Ü, Bedecs K, Andell S, Land T, Gregersen S, Ähren B, Girotti P, Consolo S, Corwin R, Crawley J, Xiaojun X, WiesenfeldHallin Z, Hökfelt T (1993) Galanin-reccptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci USA 90:11287-11291.
3. Beai MF, MacGarvey U, Swartz KJ (1990) Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease. Ann Neurol 28:157-161.
4. Bodick NC, Offen WW, Levey AI, Cutler NR, Gauthier SG, Satlin A, Shannon HE, Tollefson GD, Rasmussen K, Bymaster FP, Hurley DJ, Potter WZ, Paul SM (1997) Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer's disease. Arch Neurol 54:465-473.
5. Bowser R, Kordower JH, Mufson EJ (1997) A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease. Brain Pathol 2:723-730.
6. Butcher LL, Woolf HN (1986) Central cholinergic systems: synopsis of anatomy and overview of physiology and pathology. In: The biological substrates of Alzheimer's disease (Sheibel AB, Wechsler AF, eds), pp 73-86. New York: Academic.
7. Chan-Palay V (1988a) Galanin hyperinncrvates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol 273:543-557.
8. Chan-Palay V (1988b) Neurons with galanin innervate cholinergic cells in the human basal forebrain and galanin and acctylcholine coexist. Brain Res Bull 21:465-472.
9. Chan-Palay V (1990) Hyperinnervation of surviving neurons of the human basal nucleus of Meynert by galanin in dementias of Alzheimer's and Parkinson's disease. Adv Neurol 51:253-255.
10. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutation of the betaamyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360:672-674.
11. Consolo S, Bertorelli R, Girotti P, La Porta C, Bartfai T, Parenti M, Zambelli M (1991) Pertussis toxin-sensitive G-protein mediates galanin's inhibition of scopolamine-evoked acetylcholine release in vivo and carbachol-stimulated phosphoinositide turnover in rat ventral hippocampus. Neurosci Lett 126:29-32.
12. Crawley JN (1996) Minireview. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's disease. Life Sci 58:2185-2199.
13. Crawley JN, Wenk GL (1989) Co-existence of galanin and acetylcholine: is galanin involved in memory processes and dementia? Trends Neurosci 21:278-282.
14. Crawley JN, Robinson JK, Langel Ü, Bartfai T (1993) Galanin receptor antagonists M40 and C7 block galanin-induced feeding. Brain Res 600:268-272.
15. Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM, Morris JC, Kawas CH, Knopman DS, Earl NL, Kumar V, Doody RS (1992) A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. N Engl J Med 327:1253-1259.
16. Fisone G, Wu CF, Consolo S, Nordström Ö, Brynne N, Bartfai T, Melander T, Hökfelt T (1987) Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo and in vitro studies. Proc Natl Acad Sci USA 84:7339-7343.
17. Fisone G, Bartfai T, Nilsson S, Hökfelt T (1991) Galanin inhibits the potassium-evoked release of acetylcholine and the muscarinic receptormediated stimulation of phosphoinositide turnover in slices of monkey hippocampus. Brain Res 568:279-284.
18. Fonnum F (1969) Radiochemical microassays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem J 115:465-472.
19. Givens B, Olton DS, Crawley JN (1992) Galanin in the medial septal area impairs working memory. Brain Res 582:71-77.
20. Greenhouse SW, Geisser S (1959) On methods in the analysis of profile data. Psychometrika 24:95-112.
21. Harrington CA, Mobley SL, Wenk GL (1994) Nitric oxide formation does not underlie the memory deficits produced by ibotenate injections into the nucleus basalis of rats. Behav Neurosci 108:277-283.
22. Heckers S, Ohtake T, Wiley RG, Lappi DA, Geula C, Mesulam MM (1994) Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J Neurosci 14:1271-1289.
23. Hökfelt T, Millhorn D, Seroogy K, Tsuruo Y, Cecatelli S, Lindh B, Meister B, Melander T, Schalling M, Bartfai T, Terenius L (1987) Coexistence of peptides with classical neurotransmitters. Experientia (Basel) 43:768-780.
24. Langel Ü, Land T, Bartfai T (1992) Design of chimeric peptide ligands to galanin receptors and substance P receptors. Int J Pept Protein Res 39:516-522.
25. Leanza G, Nilsson OG, Wiley RG, Björklund A (1995) Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG-saporin: behavioural, biochemical and stereological studies in the rat. Eur J Neurosci 7:329-343.
26. Lee MG, Chrobak JJ, Sik A, Wiley RG, Buzsaki G (1994) Hippocampal theta activity following selective lesion of the septal cholinergic system. Neuroscience 62:1033-1047.
27. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu C-E, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y-H, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977.
28. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265-275.
29. Malin DH, Novy BJ, Lett-Brown A, Plotner RE, May BT, Radulescu SJ, Crothers MK, Osgood LD, Lake JR (1992) Galanin attenuates retention of one-trial reward learning. Life Sci 50:939-944.
30. McDonald MP, Crawley JN (1996) Galanin receptor antagonist M40 blocks galanin-induced choice accuracy deficits on a delayed nonmatching-to-position task. Behav Neurosci 110:1025-1032.
31. McDonald MP, Crawley JN (1997) Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease. J Psychiatry Neurosci 22:303-317.
32. 192IgG-saporin. Behav Neurosci 111:552-563.
33. Melander T, Hökfelt T, Rökaeus A (1986) Distribution of galanin-like immunoreactivity in the rat central nervous system. J Comp Neurol 248:475-517.
34. Merchenthaler I, Lopez FJ, Negro-Vilar A (1993) Anatomy and physiology of central galanin-containing pathways. Prog Neurpbiol 40:711-769.
35. Mufson EJ, Cochran E, BenzingWC, Kordower JH (1993) Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and the bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia 4:237-250.
36. 2+ channels. J Neurochem 56:739-747.
37. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Sydney, Australia: Academic.
38. Richter JA, Perry EK, Tomlinson BE (1980) Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease. Life Sci 26:1683-1689.
39. Robbins TW, McAlonan G, Muir JL, Everitt BJ (1997) Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease. Behav Brain Res 83:15-23.
40. Robinson JK, Crawley JN (1993) Intraventricular galanin impairs delayed nonmatching-to-sample performance in rats. Behav Neurosci 107:458-467.
41. Robinson JK, Crawley JN (1994) Analysis of anatomical sites at which galanin impairs delayed nonmatching to sample in rats. Behav Neurosci 108:941-950.
42. Robinson JK, Wenk GL, Wiley RG, Lappi DA, Crawley JN (1996a) 192IgG-saporin immunotoxin and ibotenic acid lesions of nucleus basalis and medial septum produce comparable deficits on delayed nonmatching to position in rats. Psychobiology 24:179-186.
43. Robinson JK, Zocchi A, Pert A, Crawley JN (1996b) Galanin microinjected into the medial septum inhibits scopolamine-induced acetylcholine overflow in the rat ventral hippocampus. Brain Res 709:81-87.
44. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, St. George-Hyslop PH (1995) Familial Alzheinier's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775-778.
45. Sarter M, Bruno JP, Dudchenko P (1990) Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification. Psychopharmacology 101:1-17.
46. 1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(l):2,5-thiadiazolyl)-l,2,5,6-tetrahydro-l-methylpyridines. J Med Chem 35: 2274-2283.
47. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St. George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
48. Skofitsch G, Jacobowitz DM (1985) Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 6:509-546.
49. Skofitsch G, Jacobowitz DM (1986) Quantitative distribution of galaninlike immunoreactivity in the rat central nervous system. Peptides 7:609-613.
50. Sleekier T, Keith AB, Wiley RG, Sahgal A (1995) Cholinergic lesions by 192 IgG-saporin and short-term recognition memory: role of the septohippocampal projection. Neuroscience 66:101-114.
51. Sundstrom E, Archer T, Melander T, Hökfelt T (1988) Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze. Neurosci Lett 88:331-335.
52. Tatemoto K, Rökaeus A, Jörnvall H, McDonald TJ, Mutt V (1983) Galanin: a novel biologically active peptide from porcine intestine. FEES Lett 164:124-128.
53. Torres EM, Perry TA, Blockland A, Wilkinson LS, Wiley RG, Lappi DA, Dunnett SB (1994) Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience 63:95-122.
54. Ukai M, Miura M, Kameyama T (1995) Effects of galanin on passive avoidance response, elevated plus-maze learning, and spontaneous alternation performance in mice. Peptides 16:1283-1286.
55. Vitiello B, Martin A, Hill J, Mack C, Molchan S, Martinez R, Murphy D, Sunderland T (1997) Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans. Neuropsychopharmacology 16:15-24.
56. Waite JJ, Wardlow ML, Chen AC, Lappi DA, Wiley RG, Thai LJ (1994) Time course of cholinergic and monoaminergic changes in rat brain after immunolesioning with 192 IgG-saporin. Neurosci Lett 169:154-158.
57. Wenk GL, Stoehr JD, Quintana G, Mobley S, Wiley RG (1994) Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J Neurosci 14:5986-5995.
58. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237-1239.
59. Wiley RG, Oeltmann TN, Lappi DA (1991) Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor. Brain Res 562:149-153.
60. Xu XJ, Wiesenfeld-Hallin Z, Langel Ü, Bedecs K, Bartfai T (1995) New high affinity peptide antagonists to the spinal galanin receptor. Br J Pharmacol 116:2076-2080.